Research and Resources

Public Comments [2007 – 2009]

Public Comments to Agencies

2009

AHI Comments to FDA on Form FDA 1932 Revisions
December 21, 2009

AHI Comments to FDA on Presenting Risk Information in Prescription Drug and Medical Device Promotion
August 25, 2009

AHI Comments to FDA on Transparency Task Force
August 7, 2009

AHI Comments to FDA on International Conference on Harmonisation Annex 6 Uniformity of Dosage Units Docket
April 14, 2009

AHI Comments to FDA on International Conference on Harmonisation Annex 7 Dissolution Test Docket
April 14, 2009

AHI Comments to FDA on International Conference on Harmonisation Annex 8 Sterility Test Docket
April 14, 2009

AHI Comments to FDA on Standardized Numerical Identification for Prescription Drug Packages Docket
April 14, 2009

AHI Comments to FDA on NADA vs Category II Supplemental NADA Docket
February 12, 2009

AHI Comments to the Office of Management and Budget Review on Drug Establishment Registration and Drug Listing Time Burden Estimate Docket
February 6, 2009

AHI Comments to FDA on Process Validation Draft Guidance Docket
January 15, 2009

2008

AHI Comments to USDA on Animal Raising Claims
November 10, 2008

AHI Comments to FDA on Extralabel Animal Drug Use Docket
October 28, 2008

AHI Comments to FDA on Minor Use and Minor Species Small Numbers Docket
July 16, 2008

2007

AHI Comments to FDA on VICH GL 30
July 23, 2007

AHI Comments to FDA on Requirements for Establishment Registration
January 26, 2007

AHI Comments to FDA on GFI 181, Blue Bird Labels
January 16, 2007

2010-2011 Public Comments